VY4 Stock Chart & Stats
€1.14
>-€0.01(-0.84%)
At close: 4:00 PM EDT
€1.14
>-€0.01(-0.84%)
Day’s Range― - ―
52-Week Range€1.00 - €2.41
Previous CloseN/A
Volume0.00
Average Volume (3M)255.00
Market Cap
€287.16M
Enterprise Value€320.28
Total Cash (Recent Filing)€186.57M
Total Debt (Recent Filing)€166.38M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Nov 10, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding248,300,000
10 Day Avg. Volume7
30 Day Avg. Volume255
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.53
Price to Sales (P/S)0.62
P/FCF Ratio10.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€3.02Price Target Upside164.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)€808.97M
Bulls Say, Bears Say
Bulls Say
Liquidity And Low LeverageStrong liquidity and no outstanding debt provide SNDL with financial flexibility to fund operations, pursue strategic opportunities, and withstand industry volatility. This conservative funding position reduces near-term balance-sheet pressure while management works to improve profitability across cannabis and alcohol retail.
Positive Cash GenerationPositive trailing-twelve-month operating and free cash flow indicate that SNDL is generating cash despite still-negative net income. Although the trajectory is volatile, internally generated funds can support investment and liquidity, reducing reliance on external financing over the next several quarters.
U.S. Medical Cannabis ExpansionThe Parallel restructuring creates a potentially significant U.S. medical cannabis platform, broadening SNDL beyond Canada and adding retail and production scale. Subject to required approvals and control conversion, the assets could materially expand market reach and establish a more diversified long-term growth engine.
Bears Say
Revenue Contraction And Incomplete ProfitabilitySNDL’s declining top line and still-negative EBIT and net margins show that recent operational improvements have not yet produced durable earnings power. Continued revenue contraction can limit operating leverage, constrain reinvestment, and make the company more dependent on cost initiatives to reach consistent profitability.
Cannabis Operations Margin CollapseThe severe cannabis-operations margin deterioration materially weakens the economics of SNDL’s production segment. Management indicated that ramp-up inefficiencies may persist in coming months, so the business could face continued cost pressure before scale, process improvements, or product execution restore acceptable profitability.
Liquor Retail WeaknessDeclining same-store sales and gross profit indicate sustained pressure in SNDL’s sizable liquor retail business, while increased promotions are reducing margin. Weak volume and profitability in this segment can offset gains elsewhere and make consolidated recovery dependent on difficult operational improvement.
SNDL News
VY4 FAQ
What was SNDL’s price range in the past 12 months?
SNDL lowest stock price was €1.00 and its highest was €2.41 in the past 12 months.
What is SNDL’s market cap?
SNDL’s market cap is €287.16M.
When is SNDL’s upcoming earnings report date?
SNDL’s upcoming earnings report date is Nov 10, 2026 which is in 56 days.
How were SNDL’s earnings last quarter?
SNDL released its earnings results on Jul 28, 2026. The company reported -€0.019 earnings per share for the quarter, missing the consensus estimate of -€0.003 by -€0.016.
Is SNDL overvalued?
According to Wall Street analysts SNDL’s price is currently Undervalued.
Does SNDL pay dividends?
SNDL does not currently pay dividends.
What is SNDL’s EPS estimate?
SNDL’s EPS estimate is -0.01.
How many shares outstanding does SNDL have?
SNDL has 248,300,000 shares outstanding.
What happened to SNDL’s price movement after its last earnings report?
SNDL reported an EPS of -€0.019 in its last earnings report, missing expectations of -€0.003. Following the earnings report the stock price went down -0.842%.
Which hedge fund is a major shareholder of SNDL?
Currently, no hedge funds are holding shares in DE:VY4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€3.02 (164.59% Upside)
€3.02 (164.59% Upside)
Blogger Sentiment
Bullish
DE:VY4 Sentiment 75%
Sector Average 62%
Sector Average 62%
Insider Transactions
Bought Shares
Worth €45.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.93%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SNDL
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
VY4 Company Deck
VY4 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The quarter presented a mixed picture: operational performance was challenged with declines in revenue, gross profit and segment-level profitability (notably in cannabis operations and liquor retail), driven by market softness and production ramp inefficiencies (Jeeter). Offsetting these headwinds, SNDL entered transformational capital and strategic positions — strong liquidity (CAD 183.2M), zero debt, accelerated share repurchases (~7% reduction in shares outstanding), deployment of profit enhancement initiatives (>CAD 20M expected), modest improvement in free cash flow, and the completion of a major parallel restructuring milestone that opens access to a sizeable U.S. medical cannabis platform with material upside. Given substantial near-term operational challenges balanced against meaningful balance sheet strength and strategic optionality, the call’s tone is cautiously constructive but mixed.View all DE:VY4 earnings summariesVY4 Stock 12 Month Forecast
Average Price Target
€3.02
▲(164.59% Upside)